{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:24:28Z","timestamp":1793741068736,"version":"4.6.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010722","name":"Harbin Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010722","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.redox.2026.104188","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T15:12:35Z","timestamp":1777129955000},"page":"104188","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["DNMT1-DUOXA1 axis discovers a novel methylation-ferroptosis circuit in bicalutamide-resistant prostate cancer"],"prefix":"10.1016","volume":"94","author":[{"given":"Shunyao","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziwen","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixing","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8130-3297","authenticated-orcid":false,"given":"Youcheng","family":"Xiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10437","key":"10.1016\/j.redox.2026.104188_bib1","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/S0140-6736(24)00651-2","article-title":"The lancet commission on prostate cancer: planning for the surge in cases","volume":"403","author":"James","year":"2024","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.redox.2026.104188_bib2","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1210\/endrev\/bnab002","article-title":"Hormonal therapy for prostate cancer","volume":"42","author":"Desai","year":"2021","journal-title":"Endocr. Rev."},{"issue":"20","key":"10.1016\/j.redox.2026.104188_bib3","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1200\/JCO.23.00041","article-title":"Darolutamide plus androgen-deprivation therapy and docetaxel in metastatic hormone-sensitive prostate cancer by disease volume and risk subgroups in the phase III ARASENS trial","volume":"41","author":"Hussain","year":"2023","journal-title":"J. Clin. Oncol."},{"issue":"10442","key":"10.1016\/j.redox.2026.104188_bib4","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/S0140-6736(24)00549-X","article-title":"Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial","volume":"403","author":"Parker","year":"2024","journal-title":"Lancet"},{"issue":"10442","key":"10.1016\/j.redox.2026.104188_bib5","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1016\/S0140-6736(24)00548-8","article-title":"Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial","volume":"403","author":"Parker","year":"2024","journal-title":"Lancet"},{"issue":"5928","key":"10.1016\/j.redox.2026.104188_bib6","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1126\/science.1168175","article-title":"Development of a second-generation antiandrogen for treatment of advanced prostate cancer","volume":"324","author":"Tran","year":"2009","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.redox.2026.104188_bib7","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1634\/theoncologist.2019-0115","article-title":"Comprehensive analysis of AR alterations in circulating tumor DNA from patients with advanced prostate cancer","volume":"25","author":"Ledet","year":"2020","journal-title":"Oncologist"},{"issue":"7","key":"10.1016\/j.redox.2026.104188_bib8","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1158\/1078-0432.CCR-15-1606","article-title":"Dysregulation of miR-212 promotes castration resistance through hnRNPH1-mediated regulation of AR and AR-V7: implications for racial disparity of prostate cancer","volume":"22","author":"Yang","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.redox.2026.104188_bib9","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s12964-022-00979-0","article-title":"The ER\u03b1-NRF2 signalling axis promotes bicalutamide resistance in prostate cancer","volume":"20","author":"Tian","year":"2022","journal-title":"Cell Commun. Signal."},{"issue":"27","key":"10.1016\/j.redox.2026.104188_bib10","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1038\/s41388-024-03057-6","article-title":"Cancer associated fibroblast secreted miR-432-5p targets CHAC1 to inhibit ferroptosis and promote acquired chemoresistance in prostate cancer","volume":"43","author":"Zhao","year":"2024","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.redox.2026.104188_bib11","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1158\/0008-5472.CAN-20-3477","article-title":"Ferroptosis inducers are a novel therapeutic approach for advanced prostate cancer","volume":"81","author":"Ghoochani","year":"2021","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.redox.2026.104188_bib12","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1186\/s12935-021-02264-5","article-title":"Roles of ferroptosis in urologic malignancies","volume":"21","author":"Zhao","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.redox.2026.104188_bib13","article-title":"Advances in ferroptosis for castration-resistant prostate cancer treatment: novel drug targets and combination therapy strategies","volume":"28","author":"Chen","year":"2024","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.redox.2026.104188_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1148117","article-title":"Metabolic syndrome-related prognostic index: predicting biochemical recurrence and differentiating between cold and hot tumors in prostate cancer","volume":"14","author":"Ren","year":"2023","journal-title":"Front. Endocrinol."},{"issue":"22","key":"10.1016\/j.redox.2026.104188_bib15","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.159491","article-title":"Immunogenetics associated with severe coccidioidomycosis","volume":"7","author":"Hsu","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.redox.2026.104188_bib16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1478-811X-12-5","article-title":"Dual oxidase maturation factor 1 (DUOXA1) overexpression increases reactive oxygen species production and inhibits murine muscle satellite cell differentiation","volume":"12","author":"Sandiford","year":"2014","journal-title":"Cell Commun. Signal."},{"issue":"1","key":"10.1016\/j.redox.2026.104188_bib17","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.neulet.2011.02.061","article-title":"p53-mediated regulation of neuronal differentiation via regulation of dual oxidase maturation factor 1","volume":"494","author":"Ostrakhovitch","year":"2011","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.redox.2026.104188_bib18","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s10549-009-0372-7","article-title":"NIP1\/DUOXA1 expression in epithelial breast cancer cells: regulation of cell adhesion and actin dynamics","volume":"119","author":"Ostrakhovitch","year":"2010","journal-title":"Breast Cancer Res. Treat."},{"issue":"4","key":"10.1016\/j.redox.2026.104188_bib19","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1158\/0008-5472.CAN-07-5782","article-title":"Silencing of DUOX NADPH oxidases by promoter hypermethylation in lung cancer","volume":"68","author":"Luxen","year":"2008","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.redox.2026.104188_bib20","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1161\/CIRCRESAHA.120.316443","article-title":"Epigenetic metabolic reprogramming of right ventricular fibroblasts in pulmonary arterial hypertension: a pyruvate dehydrogenase kinase-dependent shift in mitochondrial metabolism promotes right ventricular fibrosis","volume":"126","author":"Tian","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.redox.2026.104188_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111247","article-title":"Dihydrotestosterone-induced hair regrowth inhibition by activating androgen receptor in C57BL6 mice simulates androgenetic alopecia","volume":"137","author":"Fu","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"23","key":"10.1016\/j.redox.2026.104188_bib22","doi-asserted-by":"crossref","first-page":"6387","DOI":"10.1158\/1078-0432.CCR-20-3182","article-title":"Iron induces cell death and strengthens the efficacy of antiandrogen therapy in prostate cancer models","volume":"26","author":"Bordini","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.redox.2026.104188_bib23","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41420-023-01737-y","article-title":"Filamin a cooperates with the androgen receptor in preventing skeletal muscle senescence","volume":"9","author":"Di Donato","year":"2023","journal-title":"Cell Death Discov."},{"issue":"39","key":"10.1016\/j.redox.2026.104188_bib24","doi-asserted-by":"crossref","first-page":"6172","DOI":"10.1038\/s41388-020-01429-2","article-title":"Androgen receptor signaling regulates the transcriptome of prostate cancer cells by modulating global alternative splicing","volume":"39","author":"Shah","year":"2020","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.redox.2026.104188_bib25","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1089\/thy.2012.0003","article-title":"Regulation of dual oxidase expression and H2O2 production by thyroglobulin","volume":"22","author":"Yoshihara","year":"2012","journal-title":"Thyroid"},{"key":"10.1016\/j.redox.2026.104188_bib26","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.canlet.2018.04.029","article-title":"DUOXA1-mediated ROS production promotes cisplatin resistance by activating ATR-Chk1 pathway in ovarian cancer","volume":"428","author":"Meng","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.redox.2026.104188_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102851","article-title":"NOX family NADPH oxidases in mammals: evolutionary conservation and isoform-defining sequences","volume":"66","author":"Nazari","year":"2023","journal-title":"Redox Biol."}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231726001862?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231726001862?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:40:26Z","timestamp":1781106026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231726001862"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":27,"alternative-id":["S2213231726001862"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2026.104188","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DNMT1-DUOXA1 axis discovers a novel methylation-ferroptosis circuit in bicalutamide-resistant prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2026.104188","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104188"}}